Sign up to save your podcasts
Or
Share AI Access Brief Podcast
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
AI Access Brief Podcast
AI Access Brief Podcast episodes
- JCA Timelines & Regulatory DivergenceEpisode 53 — 12 July 2026EU JCA procedural delays, medical device expansion, transatlantic evidence challenges, and ADC portfolio implications.Hosted by Marcus and Sara.Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.Full transcript and sources at outcomes-analytica.no/podcast4 min
- Global HTA DivergenceEpisode 52 — 11 July 2026Examining divergent HTA approaches across emerging markets, with contrarian views on RWE utility and gene therapy valuation.Hosted by Marcus and Sara.Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.Full transcript and sources at outcomes-analytica.no/podcast9 min
- JCA Reports & Regulatory DivergenceEpisode 51 — 10 July 2026Analysis of latest JCA reports, CDF recommendations, NICE reversals, and cross-jurisdictional regulatory challenges with HEOR implications.Hosted by Marcus and Sara.Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.Full transcript and sources at outcomes-analytica.no/podcast5 min
- JCA Reports & Regulatory DivergenceEpisode 50 — 09 July 2026Analysis of emerging JCA reports, CDF recommendations, NICE reversal on MRD endpoints, and transatlantic regulatory divergence with HEOR implications.Hosted by Marcus and Sara.Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.Full transcript and sources at outcomes-analytica.no/podcast4 min
- JCA Reports & Global HTA ShiftsEpisode 49 — 08 July 2026EU JCA reports reveal methodological tensions, ADC CDF recommendations signal HTA gaps, NICE reversals challenge MRD endpoints, and regulatory divergence complicates HEOR strategies.Hosted by Marcus and Sara.Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.Full transcript and sources at outcomes-analytica.no/podcast4 min
- HTA Method Shifts & Digital EvidenceEpisode 48 — 07 July 2026Examining evolving HTA methodologies in Asia-Pacific, RWE adoption challenges in emerging markets, digital therapeutics evidence gaps, and orphan drug RWE complexities.Hosted by Marcus and Sara.Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.Full transcript and sources at outcomes-analytica.no/podcast6 min
- PRAC Valproate, Middle East HTA, Canada Pricing, RWE Latin America, Asia Gene TherapyEpisode 47 — 06 July 2026This episode covers PRAC valproate conclusions, HTA methodological updates in the Middle East, Canadian pricing policy developments, RWE integration challenges in Latin America, and gene therapy HEOR strategies in Asia.Hosted by Marcus and Sara.Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.Full transcript and sources at outcomes-analytica.no/podcast7 min
- JCA Reports & Regulatory DivergencesEpisode 46 — 05 July 2026Analysis of recent JCA reports, NICE reversals, and transatlantic regulatory divergences with HEOR implications.Hosted by Marcus and Sara.Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.Full transcript and sources at outcomes-analytica.no/podcast6 min
- JCA Reports & Regulatory DivergencesEpisode 45 — 04 July 2026Deep dive into emerging JCA assessments, ADC portfolio implications, surrogate endpoint reversals, transatlantic regulatory crises, and pharmacovigilance precedents.Hosted by Marcus and Sara.Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.Full transcript and sources at outcomes-analytica.no/podcast4 min
- Gene Therapy & RWE ChallengesEpisode 44 — 03 July 2026Examining gene therapy cost-effectiveness hurdles, RWE integration in HTA, PRO utility in value assessments, and evolving HTA approaches for digital health technologies.Hosted by Marcus and Sara.Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.Full transcript and sources at outcomes-analytica.no/podcast5 min
About AI Access Brief Podcast
From the publisher's feed
AI Generated Daily briefings on HEOR, HTA strategy and the evidence access landscape. For pharmaceutical and biotech professionals navigating regulatory-payer alignment, HTA submissions, and…
evidence strategy.